Ditchcarbon
  • Contact
  1. Organizations
  2. Basilea Pharmaceutica
Public Profile
Pharmaceutical Preparation Manufacturing
CH
updated a month ago

Basilea Pharmaceutica Sustainability Profile

Company website

Basilea Pharmaceutica AG, commonly referred to as Basilea, is a Swiss biopharmaceutical company headquartered in Basel, Switzerland. Founded in 2000, Basilea focuses on the development and commercialisation of innovative therapies for oncology and infectious diseases. The company has made significant strides in the pharmaceutical industry, particularly with its core products, which include advanced treatments for resistant infections and cancer. Basilea's unique approach combines cutting-edge research with a commitment to addressing unmet medical needs, positioning it as a key player in the global biopharmaceutical landscape. With a strong presence in Europe and North America, Basilea has achieved notable milestones, including successful product launches and strategic partnerships that enhance its market position. The company's dedication to innovation and patient care continues to drive its growth and reputation in the industry.

DitchCarbon Score

How does Basilea Pharmaceutica's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

28

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Basilea Pharmaceutica's score of 28 is higher than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.

51%

Let us know if this data was useful to you

Basilea Pharmaceutica's reported carbon emissions

Basilea Pharmaceutica, headquartered in Switzerland (CH), currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. Consequently, there are no recorded Scope 1, 2, or 3 emissions to analyse. Additionally, the company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments towards carbon neutrality or emissions reduction initiatives at this time. As there is no inherited emissions data from a parent company or related organisation, all information is based solely on Basilea Pharmaceutica's own disclosures. The absence of specific climate commitments or targets may reflect a broader industry context where many pharmaceutical companies are increasingly focusing on sustainability and climate action, but Basilea Pharmaceutica has yet to publicly align with such initiatives.

How Carbon Intensive is Basilea Pharmaceutica's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Basilea Pharmaceutica's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Basilea Pharmaceutica's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Basilea Pharmaceutica is in CH, which has a very low grid carbon intensity relative to other regions.

Basilea Pharmaceutica's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Basilea Pharmaceutica has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Basilea Pharmaceutica's Emissions with Industry Peers

Zealand Pharma A/S

DK
•
Pharmaceutical Preparation Manufacturing
Updated 18 days ago

Cosmo Pharmaceuticals N.V.

IE
•
Pharmaceutical Preparation Manufacturing
Updated 17 days ago

Evotec

DE
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Novartis

CH
•
Pharmaceutical Preparation Manufacturing
Updated about 23 hours ago

Almirall

ES
•
Pharmaceutical Preparation Manufacturing
Updated 7 days ago

Pharma Mar

ES
•
Pharmaceutical Preparation Manufacturing
Updated 9 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251030.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy